Multitude Therapeutics, Inc., a clinical stage biopharmaceutical company focused on the development of ADC drugs, today announced interim results from its ongoing Phase I/II open-label, multicenter ...

A group of Ford Mustang drivers took question from the media as part of the scheduled bullpen session ahead of this weekend's ...

The move came amid renewed U.S.–China tariff fears and cautious positioning ahead of next week’s SEC deadlines for spot XRP ...

As previously reported, after a nearly hourlong executive session, council members voted to revise the city’s pay ordinance ...